East Star Resources (EST), the Kazakhstan-focused explorer, announced the results of analysis of rock chips collected across the company’s five volcanogenic massive sulphide Rudny Altai belt licences from geological reconnaissance conducted in June 2022.
The company said its rock chip analyses verify and provide additional geological context to historical data, confirming the rich nature of these targets.
Chesterfield Resources (CHF) the LSE listed mineral exploration company, announced its interim results for the six months ended 30 June 2022. The company said that during the first half of 2022 it made steady progress increasing the shareholder value of both its Cyprus and Canadian assets. In Cyprus it followed up on the strong results from the Westline target area announced in December with a further set of positive assay results released in announced in February; assay results which confirmed a 12km polymetallic gold-rich geological trend.
Kavango (KAV), which appears to be following the Power Metal Resources (POW) approach of releasing a RNS every other day, said it has identified a large drill target, prospective for copper, on its Kalahari Copper Belt (KCB) Mamuno licences PL049/2020 & 052/2020.
AfriTin Mining (ATM), an African technology-metals mining company, announced its final audited results for the 2022 financial year (FY2022) ended 28 February 2022. The highlights were revenue of £13.6m (FY2021: £5.0m) up 178% driven by increased production and higher FY2022 tin prices. There was a maiden group profit before tax of £0.4m (FY2021: loss of £5.8m), a positive swing of £6.2m.
Alien Metals (UFO), a global minerals exploration and development company, announced that it has, through its wholly-owned subsidiary Iron Ore Company of Australia Pty Ltd, entered into a mandate letter providing for an exclusive right to negotiate project funding and offtake arrangements with Anglo American, in relation to the Hancock iron ore project located in the Pilbara, Western Australia. Punchy stuff.
Cobra (COBR), a gold, IOCG, and rare earth exploration company, announced a further tranche of assays from 23 holes that were drilled as part of an extensive 91-hole, 4,000m aircore drilling programme in June 2022. The company said results of this programme provide the outline of an emerging and scalable rare earth mineral province.
Nanosynth (NNN), the AIM quoted company specialising in nanoparticles, announced successful trial results with Volz Holdings v.o.s to enable both companies to develop a standard retro-fit to media production lines, that allows for the incorporation of the Company’s antiviral technology into heating, ventilation, and air conditioning.
Hercules Site Services (HERC), a technology enabled labour supply, announced that it has entered into a lease agreement for an industrial site in Nuneaton, circa 15 miles from the HS2 phase 1 (northern section) site. The company said it is expected that the Hercules Training Academy will be constructed on the site.
Polarean Imaging (POLX), the medical-imaging technology company, announced its unaudited interim results for the six months ended 30 June 2022. The company said during the first half of this year, it has focused on the approval process of its NDA, and addressing the findings related to the CRL. The FDA processes are proceeding with question and answer and other interactions with the FDA as it approaches its goal action date of 30 September 2022.
Omega (ODX), the specialist medical diagnostics company, announced that the publication of the preliminary results for the year ended 31 March 2022 will be further delayed as the company and its auditors require additional time to finalise the accounting treatment and disclosures relating to the recent sale of the CD4 business and for the auditors to complete their transactional testing. This work is now expected to be completed in mid-September.
ValiRx (VAL), a life science company, announced its half yearly report for the period ended 30 June 2022. The company said despite a challenging market, it has been able to complete a £2.5m equity raise at the period end. It now has sufficient funding to continue building the collaborative development pipeline and continue to explore options to create a translational contract research organisation.
ImmuPharma (IMM), the specialist drug discovery and development company, announced on 7 July 2022 that its US partner for Lupuzor™ (P140), Avion Pharmaceuticals, had advised that it had received Type C Meeting confirmation from the FDA. As of 30 August 2022, Avion has not yet received the written response from the FDA. The company is in close contact with Avion and have been advised that the FDA is experiencing general delays in meeting response dates.
Futura Medical (FUM), a pharmaceutical company, announced positive results from the confirmatory Phase 3 clinical study, “FM71” for MED3000 for the treatment of erectile dysfunction. Perhaps appropriately, the company said it was “excited” at the prospect of bringing a truly differentiated treatment option for men in the USA with ED without the need for a doctor’s prescription. The data generated is another important milestone for Futura, as the USA remains the largest market opportunity globally for ED treatments.
SkinBioTherapeutics (SBTX), a life science business, provided an update on the successful progress of the Oral programme and on trading following the soft launch of AxisBiotix-Ps™. The company said it was delighted with the results of the oral programme study. This latest development is testament to the continued focus on bringing innovative products to market which could benefit countless individuals and the potential they bring for many commercial opportunities.
Kazera Global (KZG), the AIM quoted investment company, confirmed that, further to the company’s announcement on 28 July 2022, the mining permit has now been granted to the Company’s 60% owned subsidiary Whale Head Minerals (Pty) Ltd, which will facilitate the start of heavy mineral sands production at the Walviskop mine in South Africa.
Dev Clever (DEV), a developer of online and immersive career guidance, announced that LaunchMyCareer.com, the company’s youth-focused, career-success platform, has appointed Rahul Dravid, former Captain of the Indian cricket team and its current Head Coach, as Dev Clever’s official brand ambassador.
It would appear that despite the cost of living crisis people will always need to use footwear. Shoe Zone (SHOE) announced that trading has continued to exceed expectations due to continued strong demand for summer and back to school products throughout August. The company also continues to benefit from the margin improvements as outlined in recent trading updates. As a result, the company now expects adjusted profit before tax for the financial year ending 2 October 2022 to be not less than £10.5m.
Ironveld (IRON) announced that it has signed the Share Purchase Agreement to acquire 100 per cent of the share capital of Ferrochrome Furnaces (Pty) Limited, which will provide Ironveld with an existing smelting facility and the opportunity to commence mining and processing in the short term.
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.
Terms of Website Use
All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned